Trials / Completed
CompletedNCT00840645
A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients
Long-term Study of YM178: Long Term Study of YM178 in Subjects With Overactive Bladder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 204 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The study is intended to test the safety, tolerability, and efficacy of long-term treatment with YM178 in patients with overactive bladder symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM178 | Oral |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2009-02-10
- Last updated
- 2016-01-05
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00840645. Inclusion in this directory is not an endorsement.